Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Asbill

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
International Journal of Pharmaceutical Compounding|August 23, 2013
The release and transdermal penetration of baclofen formulated in a poloxamer lecithin organogelJohn J Arnold, Scott Asbill
International Journal of Pharmaceutical Compounding|April 25, 2015
Skin permeation and antinociception of topical gabapentin formulationsEvan Bryson, Scott Asbill, Sarah Sweitzer
Innovations in Pharmacy|October 28, 2022
Traditional Lecture versus Case-Based Learning in a Therapeutic Drug Monitoring Course within an Integrated Pharmacy CurriculumRiley D Bowers, C Scott Asbill
Antimicrobial Agents and Chemotherapy|August 12, 2015
Naegleria fowleri: pathogenesis, diagnosis, and treatment optionsEddie Grace, Scott Asbill, Kris Virga
International Journal of Pharmaceutical Compounding|April 25, 2015
In vitro skin penetration and skin content of progesterone from various topical formulationsAllie Heustess, Scott Asbill, David Eagerton, et al.
International Journal of Pharmaceutical Compounding|May 17, 2026
Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding FacilitiesHayden R Asbill, W Mark Moore, Scott Asbill
International Journal of Pharmaceutical Compounding|August 24, 2013
Isoniazid release from suppositories compounded with selected basesKristofer C Hudson, C Scott Asbill, Andrew A Webster
International Journal of Pharmaceutical Compounding|September 20, 2013
Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogelRachel Woodall, John J Arnold, Doug McKay, et al.
International Journal of Pharmaceutical Compounding|April 11, 2024
Compounded Pain Formulations: What is the Evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
International Journal of Pharmaceutical Compounding|December 6, 2014
Compounded pain formulations: what is the evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Journal of Pharmaceutical Compounding|August 23, 2013
The release and transdermal penetration of baclofen formulated in a poloxamer lecithin organogelJohn J Arnold, Scott Asbill
International Journal of Pharmaceutical Compounding|April 25, 2015
Skin permeation and antinociception of topical gabapentin formulationsEvan Bryson, Scott Asbill, Sarah Sweitzer
Innovations in Pharmacy|October 28, 2022
Traditional Lecture versus Case-Based Learning in a Therapeutic Drug Monitoring Course within an Integrated Pharmacy CurriculumRiley D Bowers, C Scott Asbill
Antimicrobial Agents and Chemotherapy|August 12, 2015
Naegleria fowleri: pathogenesis, diagnosis, and treatment optionsEddie Grace, Scott Asbill, Kris Virga
International Journal of Pharmaceutical Compounding|April 25, 2015
In vitro skin penetration and skin content of progesterone from various topical formulationsAllie Heustess, Scott Asbill, David Eagerton, et al.
International Journal of Pharmaceutical Compounding|May 17, 2026
Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding FacilitiesHayden R Asbill, W Mark Moore, Scott Asbill
International Journal of Pharmaceutical Compounding|August 24, 2013
Isoniazid release from suppositories compounded with selected basesKristofer C Hudson, C Scott Asbill, Andrew A Webster
International Journal of Pharmaceutical Compounding|September 20, 2013
Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogelRachel Woodall, John J Arnold, Doug McKay, et al.
International Journal of Pharmaceutical Compounding|April 11, 2024
Compounded Pain Formulations: What is the Evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
International Journal of Pharmaceutical Compounding|December 6, 2014
Compounded pain formulations: what is the evidence?Scott Asbill, Sarah M Sweitzer, Shuler Spigener, et al.
Pageof 2